Patents

US 11370794 B2: Toll-like receptor antagonist compounds and methods of use

Granted
2022-06-28
Filed
2017-11-09 application 16348816
Type
Utility · 28 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention relates to compounds of formula (I): or a salt or solvate thereof, wherein the variables are as described herein. Compounds of formula (I), and pharmaceutical compositions thereof, are antagonists of toll-like receptors such as TLR7, TLR8, and/or TLR9. In certain embodiments, compounds of the invention are useful for inhibiting immune response and treating diseases associated with undesirable immune response.

Source: PVGPATDIS, file of 2026-04-10 (ipg220628.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
DYNAVAX TECHNOLOGIES CORPORATION 50 patentsUS company or organizationBerkeley, CADYNAVAX TECHNOLOGIES CORP SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Albert Frederick Candia, IIISan Mateo, CA3PVGPATDIS, file of 2026-04-10
Richard Thomas BeresisSan Francisco, CA34PVGPATDIS, file of 2026-04-10
Robert L. CoffmanPortola Valley, CA23PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D487/04PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K45/06PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2019-06-13Assignment
Assignment of assignor's interest
CANDIA, ALBERT FREDERICK, III signed 2019-05-13
BERESIS, RICHARD THOMAS signed 2019-05-15
COFFMAN, ROBERT L. signed 2019-05-13
DYNAVAX TECHNOLOGIES CORPORATION BERKELEY, CA49463/370PASDL, file of 2026-08-03

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.